1,3,5-triaza-7-phosphaadamantane has been researched along with pyridine in 1 studies
Studies (1,3,5-triaza-7-phosphaadamantane) | Trials (1,3,5-triaza-7-phosphaadamantane) | Recent Studies (post-2010) (1,3,5-triaza-7-phosphaadamantane) | Studies (pyridine) | Trials (pyridine) | Recent Studies (post-2010) (pyridine) |
---|---|---|---|---|---|
44 | 0 | 33 | 2,785 | 3 | 1,253 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bramucci, M; Jaros, SW; Kirillov, AM; Kochel, A; Lupidi, G; Petrelli, D; Pettinari, C; Quassinti, L; Smoleński, P; Vitali, LA | 1 |
1 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and pyridine
Article | Year |
---|---|
New water-soluble polypyridine silver(I) derivatives of 1,3,5-triaza-7-phosphaadamantane (PTA) with significant antimicrobial and antiproliferative activities.
Topics: Adamantane; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Bacteria; Candida albicans; Cell Line, Tumor; Cell Proliferation; DNA; Humans; Models, Molecular; Molecular Conformation; Organometallic Compounds; Organophosphorus Compounds; Pyridines; Silver; Solubility; Water | 2013 |